1.Yoo HJ. Pathogenesis and clinical implications of metabolically healthy obesity (MHO) and metaboli-cally obese normal weight (MONW) subjects. J Ko-rean Diabetes 2014;15:12-6.
2.Iacobini C, Pugliese G, Blasetti Fantauzzi C, Federi-ci M, Menini S. Metabolically healthy versus meta-bolically unhealthy obesity. Metabolism 2019;92:51-60.
5.Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjo-mataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mor-tality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-49.
6.Cantwell MM, Lacey JV Jr, Schairer C, Schatzkin A, Michaud DS. Reproductive factors, exogenous hor-mone use and bladder cancer risk in a prospective study. Int J Cancer 2006;119:2398-401.
7.Cohn JA, Vekhter B, Lyttle C, Steinberg GD, Large MC. Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nation-wide claims-based investigation. Cancer 2014;120:555-61.
8.Dobruch J, Daneshmand S, Fisch M, Lotan Y, Noon AP, Resnick MJ, et al. Gender and bladder cancer: a collaborative review of etiology, biology, and out-comes. Eur Urol 2016;69:300-10.
9.Hoffman KL, Lerner SP, Smith CL. Raloxifene in-hibits growth of RT4 urothelial carcinoma cells via estrogen receptor-dependent induction of apop-tosis and inhibition of proliferation. Horm Cancer 2013;4:24-35.
13.World Health Organization. The Asia-Pacific per-spective: redefining obesity and its treatment. Geneva (Switzerland): World Health Organization; 2000.
14.Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treat-ment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
16.Lin Y, Wang Y, Wu Q, Jin H, Ma G, Liu H, et al. Association between obesity and bladder cancer recurrence: a meta-analysis. Clin Chim Acta 2018;480:41-6.
17.Cantiello F, Cicione A, Salonia A, Autorino R, De Nunzio C, Briganti A, et al. Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: a system-atic review. Int J Urol 2015;22:22-32.
18.Jee SH, Yun JE, Park EJ, Cho ER, Park IS, Sull JW, et al. Body mass index and cancer risk in Korean men and women. Int J Cancer 2008;123:1892-6.
19.Goldbohm RA, Balder HE, van de Bosch LC, Preller L, Schouten LJ, van den Brandt PA. Is body weight associated with risk of bladder cancer?. Philadel-phia (PA): American Association for Cancer Re-search; 2006.
22.Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006;444:881-7.